These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29326355)
21. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Gent YY; Weijers K; Molthoff CF; Windhorst AD; Huisman MC; Smith DE; Kularatne SA; Jansen G; Low PS; Lammertsma AA; van der Laken CJ Arthritis Res Ther; 2013 Mar; 15(2):R37. PubMed ID: 23452511 [TBL] [Abstract][Full Text] [Related]
22. A first-in-man study of [ Tamura K; Nishii R; Tani K; Hashimoto H; Kawamura K; Zhang MR; Maeda T; Yamazaki K; Higashi T; Jinzaki M Ann Nucl Med; 2024 Apr; 38(4):264-271. PubMed ID: 38285284 [TBL] [Abstract][Full Text] [Related]
23. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038 [TBL] [Abstract][Full Text] [Related]
24. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653 [TBL] [Abstract][Full Text] [Related]
25. Quetiapine ameliorates collagen-induced arthritis in mice via the suppression of the AKT and ERK signaling pathways. Pan YJ; Wang WH; Huang TY; Weng WH; Fang CK; Chen YC; Hwang JJ Inflamm Res; 2018 Oct; 67(10):847-861. PubMed ID: 30109356 [TBL] [Abstract][Full Text] [Related]
26. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
27. Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand de Groot M; Patel N; Manavaki R; Janiczek RL; Bergstrom M; Östör A; Gerlag D; Roberts A; Graves MJ; Karkera Y; Fernando D; Mistry P; Walker A; Wisniacki N; Fryer TD; Jimenez-Royo P EJNMMI Res; 2019 Dec; 9(1):113. PubMed ID: 31858293 [TBL] [Abstract][Full Text] [Related]
28. [Positron emission tomography with (18)F-FDG in the evaluation of patients with rheumatoid arthritis--a systematic review]. dos Anjos DA; da Mota LM Rev Bras Reumatol; 2014; 54(6):474-82. PubMed ID: 25458029 [TBL] [Abstract][Full Text] [Related]
29. Assessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data. Cha JH; Lee SH; Lee SW; Park K; Moon DH; Kim K; Biswal S Korean J Radiol; 2012; 13(4):450-7. PubMed ID: 22778567 [TBL] [Abstract][Full Text] [Related]
30. [¹⁸F]DPA-714 as a biomarker for positron emission tomography imaging of rheumatoid arthritis in an animal model. Pottier G; Bernards N; Dollé F; Boisgard R Arthritis Res Ther; 2014 Mar; 16(2):R69. PubMed ID: 24621017 [TBL] [Abstract][Full Text] [Related]
31. Role of gamma delta T cells in murine collagen-induced arthritis. Peterman GM; Spencer C; Sperling AI; Bluestone JA J Immunol; 1993 Dec; 151(11):6546-58. PubMed ID: 8245484 [TBL] [Abstract][Full Text] [Related]
32. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study. Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738 [TBL] [Abstract][Full Text] [Related]
33. Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. Kawamura K; Kumata K; Takei M; Furutsuka K; Hashimoto H; Ito T; Shiomi S; Fujishiro T; Watanabe R; Igarashi N; Muto M; Yamasaki T; Yui J; Xie L; Hatori A; Zhang Y; Nemoto K; Fujibayashi Y; Zhang MR Nucl Med Biol; 2016 Jul; 43(7):445-53. PubMed ID: 27183465 [TBL] [Abstract][Full Text] [Related]
34. Glucose-6-phosphatase Expression-Mediated [ Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695 [TBL] [Abstract][Full Text] [Related]
35. GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagen-specific T-cell responses and downregulating antigen-presenting cells. Choi IA; Choi JY; Jung S; Basri F; Park S; Lee EY Int Immunopharmacol; 2017 May; 46():186-193. PubMed ID: 28314223 [TBL] [Abstract][Full Text] [Related]
37. Anti-arthritic and anti-inflammatory effects of (-)-Epicatechin-3-O-β-d-allopyranoside, a constituent of Davallia formosana. Hsiao HB; Wu JB; Lin WC Phytomedicine; 2019 Jan; 52():12-22. PubMed ID: 30599891 [TBL] [Abstract][Full Text] [Related]
38. Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo Raychaudhuri S; Abria C; Harmany ZT; Smith CM; Kundu-Raychaudhuri S; Raychaudhuri SP; Chaudhari AJ Int J Rheum Dis; 2019 Dec; 22(12):2165-2169. PubMed ID: 31659868 [TBL] [Abstract][Full Text] [Related]
39. Comparative Evaluation of Wang Z; Cai L; Xu T; Tang D; Liu L; Chen Y Contrast Media Mol Imaging; 2019; 2019():2353658. PubMed ID: 31015824 [TBL] [Abstract][Full Text] [Related]